Cyclacel Pharmaceuticals Inc (CYCC) — Cash Flow-to-Debt Ratio
Cyclacel Pharmaceuticals Inc (CYCC) has a Cash Flow-to-Debt Ratio of -1.37x as of June 2025, meaning its operating cash flow of $-1.06K could theoretically repay -1% of its total liabilities ($770.00) in one year. See cash generation quality of Cyclacel Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cyclacel Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for Cyclacel Pharmaceuticals Inc across 22 annual periods. Also explore Cyclacel Pharmaceuticals Inc (CYCC) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cyclacel Pharmaceuticals Inc (2003–2024)
Year-by-year debt coverage analysis for Cyclacel Pharmaceuticals Inc. For market capitalisation and broader financial context, see CYCC market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.27x | $-7.99 Million | $6.27 Million | ▲ +35.1% |
| 2023 | -1.97x | $-16.11 Million | $8.20 Million | ▲ +28.1% |
| 2022 | -2.73x | $-20.83 Million | $7.62 Million | ▲ +19.7% |
| 2021 | -3.41x | $-18.54 Million | $5.44 Million | ▼ -52.1% |
| 2020 | -2.24x | $-7.93 Million | $3.54 Million | ▲ +14.4% |
| 2019 | -2.62x | $-9.45 Million | $3.61 Million | ▼ -77.7% |
| 2018 | -1.47x | $-6.70 Million | $4.55 Million | ▲ +16.6% |
| 2017 | -1.77x | $-7.48 Million | $4.24 Million | ▲ +5.6% |
| 2016 | -1.87x | $-10.08 Million | $5.39 Million | ▲ +23.3% |
| 2015 | -2.44x | $-14.46 Million | $5.93 Million | ▼ -0.4% |
| 2014 | -2.43x | $-18.70 Million | $7.70 Million | ▼ -0.1% |
| 2013 | -2.43x | $-18.20 Million | $7.50 Million | ▼ -88.2% |
| 2012 | -1.29x | $-12.04 Million | $9.34 Million | ▲ +40.0% |
| 2011 | -2.15x | $-13.98 Million | $6.50 Million | ▲ +12.4% |
| 2010 | -2.46x | $-16.04 Million | $6.54 Million | ▼ -58.7% |
| 2009 | -1.55x | $-15.19 Million | $9.82 Million | ▲ +46.6% |
| 2008 | -2.90x | $-29.91 Million | $10.31 Million | ▼ -124.8% |
| 2007 | -1.29x | $-23.14 Million | $17.94 Million | ▲ +40.2% |
| 2006 | -2.16x | $-20.17 Million | $9.36 Million | ▲ +31.4% |
| 2005 | -3.14x | $-21.51 Million | $6.84 Million | ▼ -71.2% |
| 2004 | -1.84x | $-21.09 Million | $11.48 Million | ▼ -888.2% |
| 2003 | -0.19x | $-15.49 Million | $83.34 Million | — |